Juleen R. Zierath was born in Milwaukee Wisconsin in 1961. She received a B.S. from UWRF in 1984, a M.A. from Ball State University in 1986, and a Ph.D. from Karolinska Institutet in 1995. Her research focuses on the development of insulin resistance in Type 2 diabetes. She is Professor of Experimental Physiology and leads the Section of Integrative Physiology, Department of Molecular Medicine and Surgery at Karolinska Institutet, Stockholm, Sweden. She is also Professor of Integrative Physiology and Executive Director at Novo Nordisk Foundation Center for Basic Metabolic Research at University of Copenhagen, Denmark.
In 2006 she was appointed to the Nobel Assembly at Karolinska Institutet and since 2008 she is member of the Nobel Committee for Physiology or Medicine. She is previous Vice-chair and Chair of the Nobel Committee, previous Chair of the Board of Directors of the Keystone Symposia, and Past President of the European Association for the Study of Diabetes. She is currently a board member of Nobel Media and Keystone Symposia. She is member of Academia Europaea and member of the Royal Swedish Academy.
She has received several distinctions, including the Minkowski Prize from the European Association for the Study of Diabetes, the Datta Lectureship Award for outstanding achievement in the field of biochemistry and molecular biology from the Federation of European Biochemical Society, the Knud Lundbeck Award from the Scandinavian Society for the Study of Diabetes, the J.B. Wolffe Memorial Lectureship Award from the American College of Sports Medicine, an Honor Award from the International Research Group on Biochemistry of Exercise, the Nordic Medicine Prize for Research in Diabetes from the Foundation for the Nordic Medicine, an Advanced Grant from the European Research Council, and a Distinguished Professorship from Karolinska Institutet. In 2019, she received an Honorary Doctor of Science Degree from UWRF.
Wednesday 02 June